IS QUERCETIN ABLE TO REVERT THE APOPTOTIC RESISTANCE TRIGGERED BY THE SHORT ISOFORM OF GATA-1 IN MYELOID LEUKEMIA CELLS?
EHA Library, Silvia trombetti, 266630
GLYCOLYSIS VERSUS OXIDATIVE PHOSPHORYLATION - POTENTIAL THERAPEUTIC TARGETS IN AML
EHA Library, Ana Bela Sarmento-Ribeiro, 266631
CLINICAL BENEFIT OF GLASDEGIB PLUS LOW-DOSE CYTARABINE IN PATIENTS WITH DE NOVO AND SECONDARY ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL
EHA Library, Walter Fiedler, 266646
COMPLETE REMISSION WITH INCOMPLETE BLOOD COUNT RECOVERY IS A STRONG PREDICTOR OF NON-RELAPSE MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Ivetta Danylesko, 266647
INDIRECT NUMBER NEEDED TO TREAT: COMPARATIVE EFFECTIVENESS OF GLASDEGIB + LOW-DOSE CYTARABINE VS AZACITIDINE OR DECITABINE IN ACUTE MYELOID LEUKEMIA PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
EHA Library, Anna Forsythe, 266662
FLT3 LIGAND PLASMA LEVELS HAVE NO IMPACT ON OUTCOMES AFTER ALLOTRANSPLANT IN ACUTE LEUKEMIA.
EHA Library, Pierre Peterlin, 266663
ELDERLY PATIENTS WITH DE NOVO OR SECONDARY AML HAVE COMPARABLE OUTCOMES AFTER INTENSIVE TREATMENTS INCLUDING HIGH DOSE (HD) CYTARABINE AND AUTOLOGOUS (AUTO) OR ALLOGENEIC (ALLO) TRANSPLANTATION (SCT)
EHA Library, Massimo Bernardi, 266678
PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) IN DEVELOPING COUNTRIES, BARRIERS AGAINST BETTER OUTCOME 10 YEARS’ EXPERIENCE AMONG EGYPTIAN PEDIATRIC ACUTE MYELOID LEUKEMIA
EHA Library, Youssef Madney, 266679
CLINICAL OUTCOME OF INTENSIFIED CHEMO-TARGETED THERAPY IN ACTIVATED B CELL NON HODGKIN LYMPHOMA
EHA Library, Ahmed Sohaib, 266696
LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME: A SINGLE-CENTER EXPERIENCE.
EHA Library, Javier Alberto Rojas Martínez, 266697
RAPID INFUSION WITH CT-P10 IN PATIENTS WITH NON-HODGKIN’S LYMPHOMA OR CHRONIC LYMPHOCYTIC LEUKAEMIA: INTERIM RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST-AUTHORISATION SAFETY STUDY
EHA Library, Mark J Bishton, 266712
INTERIM UPDATE FROM A MULTI-CENTER STUDY OF PRALATREXATE IN ASIAN PATIENTS WITH RELAPSED OR REFRACTORY(R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)
EHA Library, Ming-Chung Wang, 266713
PATIENTS WITH GAUCHER DISEASE SHOW AN IMMUNE-DYSREGULATION PATTERN SECONDARY TO A DEFECT OF APOPTOSIS
EHA Library, Maurizio Miano, 266731
THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY
EHA Library, Yasutaka Ueda, 266732
STEM CELL FACTOR IS IMPLICATED IN MICROENVIRONMENTAL INTERACTIONS AND CELLULAR DYNAMICS OF CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, George Gavriilidis, 266747
HIGH-THROUGHPUT Β-CELL IMMUNOPROFILING AT DIAGNOSIS AND RELAPSE OFFERS FURTHER EVIDENCE OF FUNCTIONAL SELECTION THROUGHOUT THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Anna Vardi, 266748
LOW-COVERAGE WHOLE GENOME SEQUENCING OUTPERFORMS FISH IN COPY NUMBER VARIATION DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Beñat Ariceta, 266763
SPATIAL HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKAEMIA ANALYSED BY WHOLE-GENOME/EXOME SEQUENCING AT DIAGNOSIS
EHA Library, Ferran Nadeu, 266764
PATIENT-BASED PROSPECTIVE REAL WORLD DATA ANALYSIS SHOWS THAT THE DURATION OF TREATMENT INTERRUPTIONS WITH SUBSEQUENT RESUMPTION OF IDELALISIB THERAPY CAN VARY FROM DAYS TO MONTHS
EHA Library, Manuela Hoechstetter, 266780
SURVIVAL DISPARATIES IN HAIRY CELL LEUKEMIA ACROSS EUROPE: RESULTS OF RARECARENET--A POPULATION-BASED STUDY
EHA Library, Avinash Dinmohamed, 266781
TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS HARBORING ATYPICAL BCR-ABL1 TRANSCRIPTS
EHA Library, Matteo Dragani, 266796
FOLLOW-UP OF LOWER DOSE DASATINIB 50MG DAILY AS FRONTLINE THERAPY IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP)
EHA Library, Kiran Naqvi, 266797
TIME TO HEALTH-RELATED QUALITY OF LIFE IMPROVEMENT IN THE PHASE 3 BFORE TRIAL: FIRST-LINE BOSUTINIB VS IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
EHA Library, Tim H Brümmendorf, 266812
INNOVATIVE DIAGNOSTIC APPROACH FOR RARE ANEMIA
EHA Library, Valeria Rizzuto, 266813
CD22 CAR T-CELL THERAPY IN 34 REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Library, Jing PAN, 266828
UPDATED RESULTS FROM PHASE I TRIALS ASSESSING A NKG2D CAR T-CELL APPROACH IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS
EHA Library, David Sallman, 266829
SF3B1 KNOCKDOWN AT EARLY ERYTHROPOIESIS INDUCED CELL APOPTOSIS BY USING A TET-ON LENTIVIRAL VECTOR
EHA Library, Yumin Huang, 266845
CHARACTERIZING THE ETIOLOGY OF PEDIATRIC ACUTE MYELOID LEUKEMIA BY STUDYING MUTATION ACCUMULATION IN NORMAL HEMATOPOIESIS
EHA Library, Arianne Brandsma, 266846
NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY
EHA Library, Burhan Ferhanoglu, 266862
GRAFT SOURCE AND PRE-TRANSPLANT DISEASE STATUS ARE THE MAIN VARIABLES AFFECTING THE OUTCOME OF T CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR HODGKIN LYMPHOMA
EHA Library, Jacopo Mariotti, 266863
CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF 33 PATIENTS WITH SEZARY SYNDROME AT MOFFITT CANCER CENTER: A SINGLE-INSTITUTION COHORT
EHA Library, Yumeng Zhang, 266878
POST HOC ANALYSIS OF THE AUGMENT PHASE III RANDOMIZED STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA
EHA Library, Catherine Thieblemont, 266879
EVALUATION OF THE IMMUNITY TO MEASLES, MUMPS AND RUBELLA IN ADULT PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Koji Kawamura, 266894
LACTATE CLEARANCE AS A SURVIVAL PREDICTOR IN PATIENTS WITH HEMATOLOGIC DISEASES WITH SEPTIC SHOCK
EHA Library, Iurii Osipov, 266895
OSTEOGENESIS IMPERFECTA : A NEW UNRECOGNIZED ETIOLOGY FOR FUNCTIONAL IRON DEFICIENCY
EHA Library, Iman Ragab, 266910
MULTIFACTORIAL HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD
EHA Library, Fabiana Busti, 266911
A NOVEL NPM-ALK-DRIVEN MODEL OF CD30+ T-CELL LYMPHOMA
EHA Library, Khalid Shoumariyeh, 266926
THE NOVEL BISPECIFIC CD47-CD19 ANTIBODY TG-1801 POTENTIATES THE ACTIVITY OF UBLITUXIMAB-UMBRALISIB (U2) DRUG COMBINATION IN PRECLINICAL MODELS OF B-NHL
EHA Library, Marcelo L Ribeiro, 266927
IDENTIFICATION AND TARGETING OF MOLECULAR SIGNATURES OF HYPOMETHYLATING AGENT RESISTANCE IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA
EHA Library, Yue Wei, 266942
IMPLEMENTATION OF FUNCTIONAL ASSAYS TO CHARACTERIZE AND DETERMINE THE CLINICAL IMPACT OF RUNX1 VARIANTS OF UNCERTAIN SIGNIFICANCE IN SPORADIC DISEASES AS WELL AS IN THE CONTEXT OF FPDMM
EHA Library, Tim Ripperger, 266943
ABSOLUTE MONOCYTE COUNT AFFECTS PROGNOSIS IN MYELODYSPLASTIC SYNDROMES INDEPENDENTLY FROM THE IPSS-R
EHA Library, Tobias Silzle, 266957
CLINICAL SIGNIFICANCE OF KIR GENOTYPE IN JAPANESE PATIENTS WITH MYELODYSPLASTIC SYNDROME
EHA Library, Norina Tanaka, 266958
PREDICTING SURVIVAL AND TRANSFORMATION IN YOUNG AND MIDDLE-AGED PATIENTS WITH MYELODYSPLASTIC SYNDROME
EHA Library, Natalia Klimkovich, 266959
POTENT ANTI-MYELOMA EFFICACY OF DENDRITIC CELL THERAPY IN COMBINATION WITH POMALIDOMIDE AND PROGRAMMED DEATH-LIGAND 1 BLOCKADE IN A PRECLINICAL MODEL OF MULTIPLE MYELOMA
EHA Library, Je-Jung Lee, 266975
DYSREGULATED MICRORNA EXPRESSION IN CIRCULATING PLASMA CELLS IN MULTIPLE MYELOMA
EHA Library, Jana Gregorová, 266976
LONG NON-CODING RNA NEAT1 TARGETING TRIGGERS ANTI-TUMOR ACTIVITY AND RESULTS IN CHEMO-SENSITIZING EFFECT IN MULTIPLE MYELOMA CELLS
EHA Library, Elisa TAIANA, 266977
PROGNOSIS IN ELDERLY MULTIPLE MYELOMA PATIENTS IN THE HOVON-87/NMSG-18 STUDY BASED ON REVISED ISS AND SKY92-ISS
EHA Library, Rowan Kuiper, 266991
UPDATED SAFETY AND EFFICACY FROM A PHASE 2 STUDY OF VENETOCLAX PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Luciano J. Costa, 266992
LENALIDOMIDE MAINTENANCE POSITIVELY IMPACTS OUTCOMES IN MULTIPLE MYELOMA WITHOUT NEGATIVE IMPACTS IN RELAPSE: AN ANALYSIS OF REAL WORLD DATA FROM THE MYELOMA CANADA RESEARCH NETWORK NATIONAL DATABASE
EHA Library, Christopher Venner, 266993
PRELIMINARY DATA: PHASE 1B STUDY OF FEASIBILITY/SAFETY OF ISATUXIMAB SHORT DURATION FIXED VOLUME INFUSION IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Saad Usmani, 267007
ASSESSMENT OF THE BURDEN OF DISEASE IN TERMS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR ASCT IN SPAIN: INTERIM ANALYSIS OF QOLMMBUS STUDY
EHA Library, Javier De La Rubia, 267008
CONSOLIDATION WITH A SHORT COURSE OF DARATUMUMAB CAN SIGNIFICANTLY IMPROVE COMPLETE RESPONSE RATES IN PATIENTS WITH AL AMYLOIDOSIS OR LCDD
EHA Library, Efstathios Kastritis, 267009
WEEKLY CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE UNTIL PROGRESSION IN RELAPSED REFRACTORY MULTIPLE MYELOMA
EHA Library, Cecile Gruchet, 267023
TWICE WEEKLY CARFILZOMIB IS AN ACCEPTED TREATMENT BY PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY: INTERIM RESULTS OF THE CARO STUDY
EHA Library, Wolfgang Knauf, 267024
PROGNOSTIC SIGNIFICANCE OF CD56 EXPRESSION ON BONE MARROW PLASMA CELLS OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.
EHA Library, Giulia Rivoli, 267025
VENETOCLAX FOR THE TREATMENT OF MULTIPLE MYELOMA: OUTCOMES OUTSIDE OF CLINICAL TRIALS
EHA Library, M Hasib Sidiqi, 267039
NEXT-GENERATION SEQUENCING STUDY OF V(D)J REARRANGEMENTS ON NON-CR PATIENTS SHOWING MRD NEGATIVITY BY NEXT-GENERATION FLOW
EHA Library, Sung Min KIM, 267040
THE CRAB SCORE: A SIMPLE PROGNOSTIC TOOL IN MULTIPLE MYELOMA
EHA Library, Helena Bean, 267041
DATA-DRIVEN ANALYSIS OF JAK2V617F KINETICS DURING INTERFERON-ALPHA2 TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA AND RELATED NEOPLASMS
EHA Library, Vibe Skov, 267055
ENHANCED SUPPORT OF MYELOFIBROSIS STEM CELLS IN NEXT GENERATION HUMANIZED MICE
EHA Library, Veronika Lysenko, 267056
RESPONSE TO UP-FRONT AZACITIDINE IN JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML): INTERIM ANALYSIS OF THE PROSPECTIVE EUROPEAN MULTICENTER STUDY AZA-JMML-001
EHA Library, Charlotte M. Niemeyer, 267072
FAVORABLE OVERALL SURVIVAL OF IMETELSTAT-TREATED RELAPSED/REFRACTORY MYELOFIBROSIS PATIENTS COMPARED WITH CLOSELY MATCHED REAL WORLD DATA
EHA Library, Andrew Kuykendall, 267073
MAINTENANCE OF RESPONSE IN LONG-TERM TREATMENT WITH ROPEGINTERFERON ALFA-2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION-PV PHASE III TRIALS)
EHA Library, Heinz Gisslinger, 267074
MYELOPROLIFERATIVE NEOPLASMS IN KOREAN CHILDREN AND YOUNG ADULTS
EHA Library, Hyoung Soo CHOI, 267088
CURRENT PRACTICE IN THE MANAGEMENT OF ESSENTIAL THROMBOCYTEMIA AND POLYCYTHEMIA VERA: A SURVEY FROM THE FRENCH INTERGROUP OF MYELOPROLIFERATIVE NEOPLASMS (FIM) AMONG 120 HEMATOLOGISTS AND INTERNISTS
EHA Library, Guillemette FOUQUET, 267089
ULTRASONOGRAPHY VS RM FOR SPLEEN VOLUME EVALUATION IN MYELOPROLIFERATIVE NEOPLASMS: WHAT YOU NEED TO KNOW.
EHA Library, Novella Pugliese, 267090
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME IN THE ECULIZUMAB ERA: PRESENTATION, RESPONSE TO TREATMENT AND EVALUATION OF AN ECULIZUMAB WITHDRAWAL STRATEGY
EHA Library, Lucy Neave, 267105
TH1 CYTOKINE IFN-GAMMA+874T/A AND TNF-ALPHA-857C/T POLYMORPHISMS AFFECT THROMBOCYTOPENIA IN CHRONIC IMMUNE THROMBOCYTOPENIA (CITP)
EHA Library, Kana Souma, 267106
BERBERINE MAY CORRECT GUT MICROBIOTA-INDUCED CORTICOSTEROID RESISTANCE AND MESENCHYMAL STEM CELL DYSFUNCTION IN IMMUNE THROMBOCYTOPENIA BY REGULATING GUT MICROBIOTA STRUCTURE
EHA Library, Yanan Wang, 267107
CLINICAL AND ECONOMIC BURDEN OF MYELOFIBROSIS IN A LARGE US MANAGED CARE POPULATION
EHA Library, Kejal Parikh, 267122
APREPITANT AS ADJUNCT FOR THE MANAGEMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS WITH HEMATOLOGIC MALIGNANCY UNDERGOING HIGHLY EMETOGENIC CHEMOTHERAPY: A META-ANALYSIS
EHA Library, Feroni Pella Panjaitan, 267123
INCREASED VOC FREQUENCY ASSOCIATED WITH REDUCED HRQOL AMONG PATIENTS WITH SCD
EHA Library, Miranda Bailey, 267124
THE SOLUBLE GUANYLATE CYCLASE STIMULATOR OLINCIGUAT ATTENUATES LEUKOCYTE/ENDOTHELIAL CELL INTERACTIONS IN BERKELEY SCD MICE
EHA Library, Huihui Li, 267138
CENTRAL PHYSIOLOGIC MECHANISMS WHICH AUGMENT OXYGEN RELEASE (BOHR EFFECT AND 2,3-DPG BINDING) ARE PRESERVED IN THE PRESENCE OF VOXELOTOR AT THE THERAPEUTIC TARGET OF 30% HB MODIFICATION
EHA Library, Mira Pochron, 267139
THE OXYGENSCAN: A COMPREHENSIBLE FUNCTIONAL RED BLOOD CELL TEST TO MONITOR TREATMENT EFFICACY IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Minke Rab, 267140
CO-TRANSPLANTATION OF MESENCHYMAL STEM CELLS CAN AMELIORATES ACUTE GVHD AND VIREMIA AFTER ALLO-HSCT FOR APLASTIC ANEMIA: A MULTI-CENTER RETROSPECTIVE STUDY OF 75PATIENTS
EHA Library, zhen Chen, 267154
SAFETY OF HEMATOPOIETIC STEM CELL DONATION. RETROSPECTIVE ANALYSIS OF EARLY POST DONATION FOLLOW UP IN VOLUNTARY DONORS REGISTERED IN DKMS FOUNDATION DONOR CENTER, POLAND
EHA Library, Tigran Torosian, 267155
A COMPARISON OF POST ALLOGENEIC STEM CELL TRANSPLANT CHIMERISM ANALYSIS METHODS: HIGH THROUGHPUT SNP GENOTYPING ANALYSED BY MALDI-TOF MASS SPECTROMETRY VS. SHORT TANDEM REPEAT (STR) MARKER ANALYSIS.
EHA Library, Kerry Wall, 267156
CLINICAL PROFILE AND OUTCOMES IN PATIENTS RECEIVING CULTURE POSITIVE HEMATOPOIETIC STEM CELL HARVEST: RETROSPECTIVE STUDY FROM AN ONCOLOGY UNIT IN A TERTIARY CARE CENTER IN INDIA
EHA Library, Vikas Garg, 267171
STUDY OF IMMUNE HEMOLYTIC DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Jianyun Liao, 267172
BRUTON TYROSINE KINASE INHIBITOR IS AN EFFECTIVE STEROID-SPARING AGENT IN CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Library, Osman Ilhan, 267173
EVALUATION OF RISK FACTORS OF GVHD FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH Β THALASSEMIA MAJOR:10 YEARS FOLLOW-UP IN 568 PATIENTS
EHA Library, Yuelin He, 267188
HEART DISEASE AND PANCREATIC IRON IN THALASSEMIA MAJOR
EHA Library, Antonella Meloni, 267189
Β0 VS. NON-Β0 GENOTYPE: DIFFERENCES IN TDT PATIENTS
EHA Library, Antonella Meloni, 267190
EDUCATIONAL INTERVENTION ENCOURAGING APPROPRIATE USE OF BLOOD TRANSFUSIONS - EXTENDED FOLLOW UP AND COMPARATIVE STUDY
EHA Library, Oren Pasvolsky, 267204
FIBRINOLYSIS IN PATIENTS WITH CHEMOTHERAPY INDUCED THROMBOCYTOPENIA AND THE EFFECT OF PLATELET TRANSFUSION.
EHA Library, Floor Heubel-Moenen, 267205
RETROSPECTIVE ANALYSIS OF HEMOGLOBIN LEVEL IN 500 TRANSFUSION EVENTS AS A STUDY MODEL FOR THE EVALUATION OF TRANSFUSION APPROPRIATENESS
EHA Library, Roberto Crocchiolo, 267206
ROLE OF CHOROID PLEXUS STROMA IN TUMOUR CHEMORESISTANCE: A SANCTUARY FOR LEUKAEMIA CELLS IN THE CENTRAL NERVOUS SYSTEM
EHA Library, Lidia Martínez, 267220
PHF6 LOSS DRIVES IL7R ONCOGENE ADDICTION IN TLX1 DRIVEN T-ALL
EHA Library, Siebe Loontiens, 267221
INACTIVATION OF SH2B3 THROUGH CN-LOH 12Q IS UNIQUELY ASSOCIATED WITH B-CELL PRECURSOR ALL WITH IAMP21 OR OTHER CHROMOSOME 21 GAIN.
EHA Library, Paul Sinclair, 267222
RANDOMIZED PHASE III HOVON-100 STUDY OF CLOFARABINE COMBINED WITH STANDARD TREATMENT IN ADULT PATIENTS WITH NEWLY DIAGNOSED ALL
EHA Library, Anita Rijneveld, 267238
INTENSIVE PAEDIATRIC THERAPY IS AS DELIVERABLE IN ADOLESCENTS AND YOUNG ADULTS AS CHILDREN WITH ALL - PRELIMINARY RESULTS OF THE AUSTRALASIAN LEUKAEMIA AND LYMPHOMA GROUP (ALLG) ALL06 STUDY
EHA Library, Matthew GREENWOOD, 267239
CAR-T CELL THERAPY BRIDGING TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION LED TO SUPERIOR SURVIVAL FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS OUT OF REMISSION
EHA Library, Xiaohui Hu, 267240
SURVIVAL OUTCOME OF SECOND ALLOGENEIC-HCT IN ADULT ALL PATIENTS WHO RELAPSED AFTER PREVIOUS ALLOGENEIC-HCT
EHA Library, Seug Yun Yoon, 267254
TIME FROM RANDOMIZATION TO FIRST SUBSEQUENT INDUCTION/SALVAGE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN IN THE PHASE 3 INO-VATE TRIAL
EHA Library, Elias Jabbour, 267255
FEASIBLE OUTCOME OF BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULTS WITH RELAPSED OR REFRACTORY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Jae-Ho Yoon, 267256
HYPOMETHYLATING DRUGS SPECIFICALLY TARGET DNMT3A MUTATION ASSOCIATED CLONAL HEMATOPOIESIS AND ACUTE MYELOID LEUKEMIA
EHA Library, Marina Scheller-Wendorff, 267270
ACUTE MYELOID LEUKEMIA CELLS ARE DEPENDENT ON S100A4 FOR GROWTH AND SURVIVAL
EHA Library, Bader Alanazi, 267271
RIBOMETHYLOME CHANGES DEPEND ON DISTINCT PATTERNS OF C/D BOX SNORNAS IN AML SUBTPYES
EHA Library, Christian Rohde, 267288
CHARACTERIZATION OF A NOVEL, POTENT SMALL MOLECULE MDM2 ANTAGONIST WHICH ACTIVATES WILD-TYPE P53 AND INDUCES APOPTOSIS IN AML
EHA Library, Nicola Ferrari, 267289

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings